{"id":55617,"date":"2023-04-07T14:03:20","date_gmt":"2023-04-07T12:03:20","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/seagen-to-report-first-quarter-2023-financial-results-on-april-27-2023\/"},"modified":"2023-04-07T14:03:20","modified_gmt":"2023-04-07T12:03:20","slug":"seagen-to-report-first-quarter-2023-financial-results-on-april-27-2023","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/seagen-to-report-first-quarter-2023-financial-results-on-april-27-2023\/","title":{"rendered":"Seagen to Report First Quarter 2023 Financial Results on April 27, 2023"},"content":{"rendered":"
\n

BOTHELL, Wash.–(BUSINESS WIRE)–Seagen Inc. (Nasdaq: SGEN) today announced that it will report its first quarter 2023 financial results on Thursday, April 27, 2023.<\/p>\n

<\/a><\/p>\n

\nGiven the recently announced agreement to be acquired by Pfizer Inc., Seagen will not be hosting a conference call.<\/p>\n

\nAbout Seagen<\/strong><\/p>\n

\nSeagen is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in people\u2019s lives. Seagen is headquartered in the Seattle, Washington area, and has locations in California, Canada, Switzerland and the European Union. For more information on the company\u2019s marketed products and robust pipeline, visit www.seagen.com<\/a> and follow @SeagenGlobal<\/a> on Twitter.<\/p>\n

Contacts<\/b> <\/p>\n

\nFor Investors<\/i>
Douglas Maffei, Ph.D.
\n
Vice President, Investor Relations
\n
(425) 527-4881
\n
dmaffei@seagen.com<\/a><\/p>\n

\nFor Media<\/i>
David Caouette
\n
Vice President, Corporate Communications
\n
(310) 430-3476
\n
dcaouette@seagen.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

BOTHELL, Wash.–(BUSINESS WIRE)–Seagen Inc. (Nasdaq: SGEN) today announced that it will report its first quarter 2023 financial results on Thursday, April 27, 2023. Given the recently announced agreement to be acquired by Pfizer Inc., Seagen will not be hosting a conference call. About Seagen Seagen is a global biotechnology company that discovers, develops and commercializes … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55617","6":"format-standard","7":"category-industry"},"yoast_head":"\nSeagen to Report First Quarter 2023 Financial Results on April 27, 2023 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/seagen-to-report-first-quarter-2023-financial-results-on-april-27-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Seagen to Report First Quarter 2023 Financial Results on April 27, 2023 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BOTHELL, Wash.–(BUSINESS WIRE)–Seagen Inc. (Nasdaq: SGEN) today announced that it will report its first quarter 2023 financial results on Thursday, April 27, 2023. Given the recently announced agreement to be acquired by Pfizer Inc., Seagen will not be hosting a conference call. About Seagen Seagen is a global biotechnology company that discovers, develops and commercializes ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/seagen-to-report-first-quarter-2023-financial-results-on-april-27-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-07T12:03:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230407005028\/en\/828587\/21\/Seagen_Logo_RGB.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/seagen-to-report-first-quarter-2023-financial-results-on-april-27-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/seagen-to-report-first-quarter-2023-financial-results-on-april-27-2023\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Seagen to Report First Quarter 2023 Financial Results on April 27, 2023\",\"datePublished\":\"2023-04-07T12:03:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/seagen-to-report-first-quarter-2023-financial-results-on-april-27-2023\\\/\"},\"wordCount\":143,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/seagen-to-report-first-quarter-2023-financial-results-on-april-27-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230407005028\\\/en\\\/828587\\\/21\\\/Seagen_Logo_RGB.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/seagen-to-report-first-quarter-2023-financial-results-on-april-27-2023\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/seagen-to-report-first-quarter-2023-financial-results-on-april-27-2023\\\/\",\"name\":\"Seagen to Report First Quarter 2023 Financial Results on April 27, 2023 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/seagen-to-report-first-quarter-2023-financial-results-on-april-27-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/seagen-to-report-first-quarter-2023-financial-results-on-april-27-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230407005028\\\/en\\\/828587\\\/21\\\/Seagen_Logo_RGB.jpg\",\"datePublished\":\"2023-04-07T12:03:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/seagen-to-report-first-quarter-2023-financial-results-on-april-27-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/seagen-to-report-first-quarter-2023-financial-results-on-april-27-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/seagen-to-report-first-quarter-2023-financial-results-on-april-27-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230407005028\\\/en\\\/828587\\\/21\\\/Seagen_Logo_RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230407005028\\\/en\\\/828587\\\/21\\\/Seagen_Logo_RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/seagen-to-report-first-quarter-2023-financial-results-on-april-27-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Seagen to Report First Quarter 2023 Financial Results on April 27, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Seagen to Report First Quarter 2023 Financial Results on April 27, 2023 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/seagen-to-report-first-quarter-2023-financial-results-on-april-27-2023\/","og_locale":"en_US","og_type":"article","og_title":"Seagen to Report First Quarter 2023 Financial Results on April 27, 2023 - Pharma Trend","og_description":"BOTHELL, Wash.–(BUSINESS WIRE)–Seagen Inc. (Nasdaq: SGEN) today announced that it will report its first quarter 2023 financial results on Thursday, April 27, 2023. Given the recently announced agreement to be acquired by Pfizer Inc., Seagen will not be hosting a conference call. About Seagen Seagen is a global biotechnology company that discovers, develops and commercializes ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/seagen-to-report-first-quarter-2023-financial-results-on-april-27-2023\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-07T12:03:20+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230407005028\/en\/828587\/21\/Seagen_Logo_RGB.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/seagen-to-report-first-quarter-2023-financial-results-on-april-27-2023\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/seagen-to-report-first-quarter-2023-financial-results-on-april-27-2023\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Seagen to Report First Quarter 2023 Financial Results on April 27, 2023","datePublished":"2023-04-07T12:03:20+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/seagen-to-report-first-quarter-2023-financial-results-on-april-27-2023\/"},"wordCount":143,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/seagen-to-report-first-quarter-2023-financial-results-on-april-27-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230407005028\/en\/828587\/21\/Seagen_Logo_RGB.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/seagen-to-report-first-quarter-2023-financial-results-on-april-27-2023\/","url":"https:\/\/pharma-trend.com\/en\/seagen-to-report-first-quarter-2023-financial-results-on-april-27-2023\/","name":"Seagen to Report First Quarter 2023 Financial Results on April 27, 2023 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/seagen-to-report-first-quarter-2023-financial-results-on-april-27-2023\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/seagen-to-report-first-quarter-2023-financial-results-on-april-27-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230407005028\/en\/828587\/21\/Seagen_Logo_RGB.jpg","datePublished":"2023-04-07T12:03:20+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/seagen-to-report-first-quarter-2023-financial-results-on-april-27-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/seagen-to-report-first-quarter-2023-financial-results-on-april-27-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/seagen-to-report-first-quarter-2023-financial-results-on-april-27-2023\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230407005028\/en\/828587\/21\/Seagen_Logo_RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230407005028\/en\/828587\/21\/Seagen_Logo_RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/seagen-to-report-first-quarter-2023-financial-results-on-april-27-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Seagen to Report First Quarter 2023 Financial Results on April 27, 2023"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55617","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55617"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55617\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55617"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55617"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55617"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}